Low expression of bcl-2 in Brca1-associated breast cancers
Open Access
- 1 November 2000
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 83 (10) , 1318-1322
- https://doi.org/10.1054/bjoc.2000.1438
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- BRCA1 and BRCA2 in breast cancerBreast Cancer Research and Treatment, 1999
- Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.1996
- p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.Journal of Clinical Oncology, 1996
- The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistryJNCI Journal of the National Cancer Institute, 1996
- Prognostic value of bcl-2 expression in invasive breast cancerBritish Journal of Cancer, 1995
- Histoprognostic grade in BRCA1-associated breast cancerThe Lancet, 1995
- Immunocytochemical localization of BCL‐2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyInternational Journal of Cancer, 1994
- Bcl-2 protein expression and long-term survival in breast cancer.1994
- Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.1994
- bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancerBritish Journal of Cancer, 1994